Latest news
Expedition Therapeutics Announces Oversubscribed $115 Million Series B Financing to Advance Next-Generation DPP1 Inhibitor for COPD - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTInocras Raises $31 Million In Oversubscribed Series B-3, Bringing Total Funding To $100 Million - Pulse 2.0Pulse 2.0 · Mon, 03 Aug 2026 12:30:48 GMTInocras Closes $31 Million in Oversubscribed Series B-3 Financing to Accelerate U.S. Commercial Expansion - Business WireBusiness Wire · Mon, 03 Aug 2026 12:00:00 GMT